|
| |
| | | 68912 | | 04.08.2023 | | Mepha Pharma AG | | | | | | | 03.08.2028 | | | | | | | | | | 02.04.40. | | |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Betahistin-Mepha Teva 16 mg | Tabletten | Tabletten (Betahistini Dihydrochloridum 16 mg) | N07CA01 | | | 02 | Betahistin-Mepha Teva 24 mg | Tabletten | Tabletten (Betahistini Dihydrochloridum 24 mg) | N07CA01 | |
|
|
|
